Oragenics (OGEN) Gross Margin (2010 - 2014)
Oragenics' (OGEN) quarterly Gross Margin came in at 58.95% in Q4 2014, down 2280.0% YoY from 2.7% in Q4 2013, and down 6.92% on a QoQ basis from 63.33% in Q3 2014.
Oragenics (OGEN) Gross Margin (2010 - 2014) Analysis & Trends
Oragenics (OGEN) has 5 years of Gross Margin data on file, last reported at 58.95% in Q4 2014.
- Quarterly Gross Margin fell 2280.0% year-over-year to 58.95% in Q4 2014, while the trailing twelve-month figure through Sep 2015 was 147.73% (up 7879.0% YoY) and the FY2014 annual result came in at 60.68%, down 606.0% from the prior year.
- Gross Margin fell to 58.95% in Q4 2014, from 63.33% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 81.75% in Q4 2013 to a low of 46.97% in Q4 2010.
- A 5-year average of 48.03% and a median of 58.65% in 2014 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2011 — Gross Margin jumped 10778 bps — and 2012, when it plunged 5462 bps.
- Tracing OGEN's Gross Margin over 5 years: stood at 46.97% in 2010, then jumped by 229 bps to 60.81% in 2011, then tumbled by 90 bps to 6.19% in 2012, then soared by 1221 bps to 81.75% in 2013, then fell by 28 bps to 58.95% in 2014.
- The last three Gross Margin figures came in at 58.95% (Q4 2014), 63.33% (Q3 2014), and 58.65% (Q2 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 58.95% |
| Sep 30, 2014 | 63.33% |
| Jun 30, 2014 | 58.65% |
| Mar 31, 2014 | 62.84% |
| Dec 31, 2013 | 81.75% |
| Sep 30, 2013 | 55.25% |
| Jun 30, 2013 | 48.32% |
| Mar 31, 2013 | 63.75% |
| Dec 31, 2012 | 6.19% |
| Sep 30, 2012 | 37.91% |
| Jun 30, 2012 | 56.22% |
| Mar 31, 2012 | 47.91% |
| Dec 31, 2011 | 60.81% |
| Sep 30, 2011 | 61.64% |
| Jun 30, 2011 | 5.40% |
| Mar 31, 2011 | 72.86% |
| Dec 31, 2010 | -46.97% |
| Sep 30, 2010 | 59.61% |
| Jun 30, 2010 | 58.18% |